Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women
Part of paid clinical trials in Harrison, New York.
- Sponsor
- Bonafide Health
- Study ID
- NCT07408115
- Status
- Completed
Conditions
- Hot Flash
- Hot Flashes
- Hot Flushes
- Hot Flushes and/or Sweats
- Hot Flushes, Menopause, Postmenopause
- Night Sweats
- Vasomotor Symptoms
- Vasomotor Symptoms (VMS)
- Vasomotor Symptoms Associated With Menopause
Eligibility Criteria
- Sex
- FEMALE
- Age
- 40 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- JDS-HF3.0 — DIETARY_SUPPLEMENTActive Supplement JDS-HF3.0
Study Details
The goal of this study is to evaluate the efficacy of a neurokinin 1,3 antagonist on improving vasomotor symptoms (VMS) and overall menopause symptoms in women between the ages of 40-70. The primary research question is whether taking the study product daily for 4 weeks with an optional 8 week extension, significantly reduces the severity and frequency of menopause-related symptoms.
Key Dates
- Start date
- May 24, 2024
- Status verified
- Feb 2026
- Primary completion
- Dec 18, 2024
- Completion
- Dec 18, 2024
Study Design
- Enrollment
- 112 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Active: JDS-HF3.0 Active GroupAll participants supplementing with JDS-HF3.0
Primary Outcome Measure
Change from Baseline on Hot Flash Symptoms assessed by the number and severity of hot flashes and times awakened at night due to night sweats collected via participant diary tracking electronically. [ Time Frame: From enrollment to initial end of study at 8 weeks and/or end of study at optional 12 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Bonafide Health | Harrison | New York | 10528 | - |
Find similar trials in Harrison, NY
By condition
By specialty
By research site
Related Studies
- JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal WomenRecruiting · Bonafide Health · Harrison, New York
- Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer PatientsPHASE2 · Recruiting · University of Arkansas · Little Rock, Arkansas
- Hot Flashes and Neurovascular Function in WomenRecruiting · Mayo Clinic · Rochester, Minnesota
- The Cardiovascular Impact of Hot FlushesRecruiting · University of Minnesota · Minneapolis, Minnesota